Carnegie Mellon researchers have used FRESH 3D bioprinting to create the first collagen-based microphysiologic systems, offering new hope for Type 1 diabetes treatment. Collagen is widely recognized for its role in maintaining healthy skin, but its importance extends far beyond that. As the most